NDC 0591-0822 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0822
- Package NDCs from labels
- 0591-0822-01, 0591-0822-05
- Manufacturer
- Watson Labs
- Effective date
- 2007-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Watson Labs | Watson Labs | 2007-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0822-01 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0822-05 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Naproxen | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Naproxen | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Croscarmellose sodium | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Povidone | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic black iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic red iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic yellow iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | 727913f6-9542-4a2d-9318-4b7ff521bffd | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals of New York LLC | 2718e0b7-1ce6-457e-bee9-11b634dfd353 | 2025-03-14 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | Direct_Rx | f499a207-02c8-a338-e053-2995a90accc0 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 198012 |
| NAPROXEN | NAPROXEN | DIRECT RX | b1b78c49-82e9-2402-e053-2a95a90ae35f | 2025-01-17 | Warnings | 198014 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9ad850-57b5-a21d-e053-2a95a90ae68e | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9a94a8-3825-eabd-e053-2a95a90acd58 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9a96cf-1cda-8ace-e053-2a95a90a18cc | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9ac948-4405-5abf-e053-2995a90af2b5 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9aa7a0-e287-5935-e053-2995a90a1d11 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Advanced Rx Pharmacy of Tennessee, LLC | d292f376-1844-b01c-e053-2a95a90a0927 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Quality Care Products, LLC | 1acfb8cc-6faf-4b3e-9304-4819c42de0a6 | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naprotin | NAPROXEN , CAPSAICIN | PureTek Corporation | dc2d2783-2a73-cb7c-e053-2995a90a9961 | 2024-12-13 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | MARKSANS PHARMA LIMITED | 1fdb4cbd-e9e8-47bb-b3d8-1f1ec8f411c8 | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | da61463f-f87b-4aba-b538-7264252cadb8 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 1fe9a6fc-940e-4a18-b3e9-b204fd67f263 | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 205b1159-06e5-0d48-e063-6294a90acbd8 | 2024-08-23 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | a4f31070-4ee1-4d64-8b1d-40b9011e124b | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | NuCare Pharmaceuticals, Inc. | 46dd3908-6feb-4f50-e054-00144ff88e88 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | NuCare Pharmaceuticals, Inc. | 3e8bcc59-dab1-1b4c-e054-00144ff88e88 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | 198014 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 5487dee2-5c37-4348-e054-00144ff8d46c | 2024-07-17 | Warnings | 198014 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.